MarketPeel
Insider Trading Intelligence
DK

D. Jeffrey Keyser

LTRN
DIRECTOR · LANTERN PHARMA INC. · CIK 0001393516
FILING MIX · LIFETIME69%/31%
BUYS
11
SELLS
5
TOTAL VALUE
$262.0K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
94,303
AVG SELL PX
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by D. Jeffrey Keyser, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-13.71%+3.71%-17.43%-17.43%
14d1+0.00%-19.06%+2.69%-21.75%-21.75%
30d1+0.00%-15.12%+6.11%-21.23%-21.23%
60d1+0.00%-24.28%+12.12%-36.40%-36.40%
90d1+0.00%-1.47%+13.53%-15.00%-15.00%
180d1+100.00%+2.68%+24.18%-21.50%-21.50%
1y1+100.00%+4.21%+43.42%-39.20%-39.20%
2y1+0.00%-63.95%+33.49%-97.44%-97.44%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LTRN · 94,303 shares · as of May 12, 2026
023,57647,15270,72794,303202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 5 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LTRN
LANTERN PHARMA INC.
PURCHASE
48,544$2.06$100.0K94,303May 12, 2026May 14, 2026View →
LTRN
LANTERN PHARMA INC.
SALE
48,54448,544May 12, 2026May 14, 2026View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
28,84428,844Jan 9, 2026Jan 12, 2026View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
25,00025,000Jan 9, 2026Jan 12, 2026View →
LTRN
LANTERN PHARMA INC.
PURCHASE
3,832$3.13$12.0K0Jul 24, 2024Jul 25, 2024View →
LTRN
LANTERN PHARMA INC.
SALE
3,8320Jul 24, 2024Jul 25, 2024View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
5,0005,000Jul 15, 2024Jul 17, 2024View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
3,2003,200Nov 4, 2021Sep 22, 2025View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
3,2003,200Nov 4, 2021Nov 5, 2021View →
LTRN
LANTERN PHARMA INC.
SALE
3,2000Nov 4, 2021Sep 22, 2025View →
LTRN
LANTERN PHARMA INC.
SALE
9,1350Jun 15, 2020Sep 22, 2025View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
9,1359,135Jun 15, 2020Sep 22, 2025View →
LTRN
LANTERN PHARMA INC.
SALE
18,3490Jun 15, 2020Jun 15, 2020View →
LTRN
LANTERN PHARMA INC.
PURCHASEGRANT
Stock grant
9,1359,135Jun 15, 2020Jun 15, 2020View →
LTRN
LANTERN PHARMA INC.
PURCHASE
31,92741,927Jun 15, 2020Jun 15, 2020View →
LTRN
LANTERN PHARMA INC.
PURCHASE
10,000$15.00$150.0K10,000Jun 11, 2020Jun 15, 2020View →
Other insiders · LTRN
Loading peer insiders…
About this filer
CIK 0001393516
ROLE
Director
PRIMARY
LTRN
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001393516DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback